首页 | 本学科首页   官方微博 | 高级检索  
检索        


Motesanib Plus Carboplatin/Paclitaxel in Patients With Advanced Squamous Non–Small-Cell Lung Cancer: Results From the Randomized Controlled MONET1 Study
Institution:2. Thoracic Surgery Department, Zaporizhzhya State Medical University, Zaporizhzhya, Ukraine;3. Sumy Regional Oncology Centre, Sumy State University, Sumy, Ukraine;4. Centrul de Oncologie Medicala, Iasi, Romania;6. Central Hospital Bad Berka, Bad Berka, Germany;5. Department of Medical Oncology, The Christie National Health Services Foundation Trust, Manchester, United Kingdom;11. Sarah Cannon Research Institute and Tennessee Oncology, PLLC, Nashville, TN
Abstract:
Keywords:Squamous histology  NSCLC  Motesanib  Carboplatin  Paclitaxel
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号